Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Complete Genomics Inc.

Division of BGI Genomics Co. Ltd.
www.completegenomics.com

Latest From Complete Genomics Inc.

Vortex Biosciences Takes On Board Becton Dickinson Alumnus

Net Scientific's portfolio company and circulating tumor cell capture specialist Vortex Biosciences adds to its board of directors Deborah Neff, ex-chief operating officer of Complete Genomics and a former BD executive.

Appointments In Vitro Diagnostics

China Dips Its Toes in Disruptive IVD Tech

The number of Chinese IVD companies exhibiting at the 2015 American Association for Clinical Chemistry Annual Meeting (AACC) & Clinical Lab Expo (CLE) was slightly down from last year, but the breadth of diagnostic products and innovations from China appears to be on the up. Hrishi Poola and Jon Chen discuss the moves China is making to become a generator of disruptive technologies and reports on the new products and the players emerging from this market

Medical Device China

China At Forefront Of Next Generation Sequencing: BGI CEO

From screening for cancer to providing individualized treatment, from rare diseases to the first in vitro fertilized (IVF) baby with modified genes, China has much to offer in the heating global race for next generation gene sequencing. Big data and the internet of genomics are just some examples, says Wang Jun, CEO of BGI, the world’s largest genomics organization.

BioPharmaceutical China

Device/Diagnostics Quarterly Deal Statistics, Q1 2013

Device companies kicked off 2013 by raising $1.1 billion via 45 transactions; the only device M&A transaction in Q1 to exceed the billion-dollar mark was Cardinal Health Inc.’s $2.07 billion acquisition of AssuraMed. Diagnostics firms began 2013 by raising a total of $286 million in the opening quarter, a 46% improvement over Q4 2012’s tally.

Medical Device Deals
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
    • Nanotechnology, Chips, etc.
  • Research, Analytical Equipment & Supplies
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • BGI Genomics Co. Ltd.
  • Senior Management
  • Clifford A Reid, PhD, Chmn., Pres., & CEO
    Radoje T Drmanac, PhD, CSO
    Keith Raffel , SVP, Chief Commercial Officer
  • Contact Info
  • Complete Genomics Inc.
    Phone: (650) 943-2800
    2071 Stierlin Ct.
    Mountain View, CA 94043
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register